We are international
Donate
TEXT SIZE   


Myeloma Matrix VELCADE® Supplement
IMPORTANT NOTE: In June, 2008, VELCADE®’s approval was expanded to include previously untreated myeloma patients. This document presents the Current Status of VELCADE® in U.S. and Foreign Clinical Trials as of May 2008.
06.05.08












IMPORTANT NOTE: In June, 2008, VELCADE®’s approval was expanded to include previously untreated myeloma patients. This document presents the Current Status of VELCADE® in U.S. and Foreign Clinical Trials as of May 2008.


 related articles